PF-Atlas › Clinical Trials › NCT07559175

A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.

NHS7108 · Phase 2

Registry ID

NCT07559175

Phase

Phase 2

Status

Not yet recruiting

Drug / intervention

NHS7108

Sponsor

Aimmune Nestlé Health Science US R&D, LLC

Start

2026-04

About this trial

NHS7108 is evaluated in NCT07559175, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Aimmune Nestlé Health Science US R&D, LLC. Current status: Not yet recruiting.

View NCT07559175 on ClinicalTrials.gov →

Explore related

All NHS7108 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT07559175 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.